Aug 26, 2026 02:43AM
Jul 14, 2026 11:39AM
Jul 13, 2026 10:38PM
Jul 13, 2026 10:37PM
Jul 13, 2026 12:02AM
Jun 30, 2026 02:44AM
May 20, 2026 03:30AM BioArctic Interim Report for the period January - March 2026
May 15, 2026 02:55AM
May 8, 2026 02:48AM
May 8, 2026 02:48AM
May 8, 2026 02:47AM
Mar 23, 2026 03:50AM
Feb 6, 2026 06:17AM
Nov 13, 2025 02:19AM Interim Report for the period July - September 2025: BioArctic
Oct 26, 2025 10:56PM
Sep 2, 2025 11:01PM
Aug 29, 2025 06:11PM
Aug 29, 2025 06:11PM
May 15, 2025 04:56AM
May 8, 2025 07:49AM
Apr 1, 2025 06:14AM The European Commission refers lecanemab decision to Appeal Committee
Mar 25, 2025 03:08AM
Feb 18, 2025 02:13AM
Jan 26, 2025 09:50PM
Dec 4, 2024 09:44PM
Jul 30, 2024 05:19PM
Jul 26, 2024 07:49AM
Jul 26, 2024 06:59AM CHMP has adopted a negative opinion on lecanemab for the EU
Jul 23, 2024 02:42AM
May 14, 2024 10:52PM
Mar 31, 2024 11:19PM
Mar 11, 2024 03:18AM
Feb 29, 2024 02:52AM
Feb 5, 2024 11:01PM
Jan 11, 2024 01:16AM The European Medicines Agency's Scientific Advisory Group (SAG) to discuss the Marketing Authorisation Application for lecanemab: BioArctic
Sep 27, 2022 11:10PM
Oct 21, 2018 08:55AM

329,625 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All